AMBUJACEM.BOAMBUJACEM.BO
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1.24% | +14.76% | +11.18% | +23.25% | +21.47% |
| Gross Profit Growth | -5.50% | +8.71% | +19.37% | +5.57% | -0.65% |
| EBITDA Growth | -17.25% | -13.69% | +0.16% | +93.56% | +67.22% |
| Operating Income Growth | -11.79% | +7.07% | +31.04% | -53.22% | -60.52% |
| Net Income Growth | -42.50% | +157.01% | -9.08% | +21.90% | +287.25% |
| EPS Growth | -53.63% | +107.49% | -26.65% | +19.85% | +286.49% |
| EPS Diluted Growth | -50.53% | +122.54% | -18.66% | +20.75% | +286.49% |
| Weighted Average Shares Growth | +24.02% | +24.02% | +11.89% | +1.71% | +0.20% |
| Weighted Average Shares Diluted Growth | +16.25% | +15.49% | +11.88% | +0.95% | +0.20% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -12.43% | +0.00% | -40.60% | +0.00% | -1.59% |
| Inventory Growth | +15.88% | +0.00% | -14.45% | +0.00% | +29.38% |
| Asset Growth | +43.45% | +0.00% | +23.96% | +0.00% | +15.85% |
| Book Value per Share Growth | +23.44% | +19.87% | +15.23% | +23.38% | +11.43% |
| Debt Growth | +4.57% | +0.00% | +12.80% | +0.00% | +63.07% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +1.50% | +10.83% | +13.21% | +17.70% | +57.31% |